Average age from diagnosis to death is 3 to 10 years.
Risk increases exponentially with age from 1% under age 65 to 25%-50% over age 85.
Characteristics | Cortical Dementia | Subcortical |
---|---|---|
Attention | Decreased | Decreased |
Memory | Prominent memory impairment Recognition deficits >recall | Retrieval and recall deficits >recognition Less severe intellectual and memory dysfunction |
Language | Prominent deficits with aphasia and agnosia | Decreased verbal fluency without anomia Dysarthria may be present |
Executive function | Varies with course | Poor and disproportionately affected |
Cognition | Impaired judgment, abstraction, and calculation | Impaired problem solving and decision making |
Emotion | Absent early in disease Tendency to minimize deficits Psychosis/agitation later in course | Apathy Prominent affective changes with depressed mood/affective lability |
Motivation | Alert, attentive, ambulatory | Decreased with bradyphrenia (slowed mental processing) |
Motor abnormalities | Lack prominent signs Preserved motor function, gait, and posture Apraxia | Prominent with gait abnormalities Tremor, tics, dystonia, extrapyramidal symptoms may be present |
Visuospatial skills | Present | Later in disease |
Examples | Alzheimer type Frontotemporal Creutzfeldt-Jakob disease | Dementias due to HIV, Parkinson disease, Huntington disease, multiple sclerosis |
Features | Dementia of the | Frontotemporal Dementia |
---|---|---|
Course | Insidious onset and steady progression | Earlier age (<65) Insidious onset and slow progression |
Presenting symptoms | Memory loss with poor insight Impaired functioning in independent activities such as driving to unfamiliar places and financial management | Personality changes Social and personal disinhibition Affective blunting Loss of insight |
Cognitive deficits | Memory impairment Language disturbance Impaired executive functioning Apraxia and agnosia | Intact visuospatial skills Severe impairment in executive functions Progressive expressive aphasia and mutism later in course |
Mood/personality disturbances | Mood Depression common, especially in mild cases Anxiety Affective lability Agitation with worsening of illness Personality Disinhibition common Apathy and agitation increase as illness progresses | Mood Prominent depression Suicidality Anxiety Personality Severe apathy and disinhibition (e.g., sexually and aggressive) |
Psychotic/behavioral disturbances | Psychosis Delusions: persecutory, theft themes common Visual hallucinations common Behavioral Increasing agitation (e.g., wandering, pacing) as disease progresses Verbal and physical aggression often accompanies psychosis | Psychosis Bizarre delusions Behavioral Poor social and interpersonal regulation and awareness Stereotyped and impulsive behavior Severe compulsions (e.g., hyperorality) Somatic preoccupation |
Motor abnormalities | Not prominent early in disease Visuospatial difficulties (e.g., constructional apraxia) | Frontal lobe release reflexes early in course Akinesia/bradykinesia, ataxia, perseveration of movements, rigidity, and tremor late in course |
Neuropathology | Neuritic plaques consisting of beta-amyloid protein deposits Neurofibrillary tangles consisting of hyperphosphorylated tau Loss of neurons in the nucleus basalis of Meynert | Frontal and anterior temporal lobe atrophy Abnormal function of the cytoskeletal protein tau Pick disease: presence of massed argentophilic inclusion-containing neurons (Pick’s bodies) |
Special considerations | Typical decline in MMSE scores in DAT is 2-4 points per year Risk factors include family history, limited cognitive reserve, increased age, female, smoking, never married, Down syndrome, apolipoprotein E (APOE) e4 allele, history of head trauma Higher educational attainment/increased cognitive reserve is protective | May be misdiagnosed as substance use, hypomania, personality disorders, and/or schizophrenia |
Refer to Chapter 36 on HIV/AIDS.
Refer to Chapter 33 on Parkinson disease.
Refer to Chapter 32 on Huntington disease.
Refer to Chapter 26 on multiple sclerosis.Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree